Supernus Pharmaceuticals, Inc
Supernus Pharmaceuticals, Inc lists 12 drug products in the FDA National Drug Code directory.
Products
| NDC | Product | Strength | Type |
|---|---|---|---|
| 17772-085 | Gocovri Capsule, Coated Pellets | Amantadine 68.5 mg/1 | Rx |
| 17772-170 | Gocovri Capsule, Coated Pellets | Amantadine 137 mg/1 | Rx |
| 17772-121 | Oxtellar Xr Tablet | Oxcarbazepine 150 mg/1 | Rx |
| 17772-122 | Oxtellar Xr Tablet | Oxcarbazepine 300 mg/1 | Rx |
| 17772-123 | Oxtellar Xr Tablet | Oxcarbazepine 600 mg/1 | Rx |
| 17772-131 | Qelbree Capsule, Extended Release | Viloxazine Hydrochloride 100 mg/1 | Rx |
| 17772-132 | Qelbree Capsule, Extended Release | Viloxazine Hydrochloride 150 mg/1 | Rx |
| 17772-133 | Qelbree Capsule, Extended Release | Viloxazine Hydrochloride 200 mg/1 | Rx |
| 17772-101 | Trokendi XR Capsule, Extended Release | Topiramate 25 mg/1 | Rx |
| 17772-102 | Trokendi XR Capsule, Extended Release | Topiramate 50 mg/1 | Rx |
| 17772-103 | Trokendi XR Capsule, Extended Release | Topiramate 100 mg/1 | Rx |
| 17772-104 | Trokendi XR Capsule, Extended Release | Topiramate 200 mg/1 | Rx |